Does age or sex make a difference in how well newer glucose-lowering drugs work in patients with type 2 diabetes? SGLT2 inhibitors may be more effective in reducing cardiovascular events in older adults with type 2 #diabetes. ➡️ Read more: ja.ma/3Cqvk7z #MedSky

Our new paper in @jama.com on age and sex differences in efficacy of type 2 diabetes treatments. It shows that older age is associated with greater cardiovascular benefits of SGLT2 inhibitors despite smaller improvement in HbA1c compared to younger people. jamanetwork.com/journals/jam...

GP practices in deprived areas should be prioritised for resource, in order to allow them to provide effective care to some of the most unwell and vulnerable patients in society. New study by Dr Marianne McCallum, Prof Sara Macdonald and @francesmair.bsky.social www.gla.ac.uk/news/headlin...